- Home
- TCRX vs PSQH Comparison
TCRX vs PSQH Comparison
Compare TCRX & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- PSQH
- Stock Information
- Founded
- TCRX 2018
- PSQH 2021
- Country
- TCRX United States
- PSQH United States
- Employees
- TCRX N/A
- PSQH N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- PSQH Advertising
- Sector
- TCRX Health Care
- PSQH Consumer Discretionary
- Exchange
- TCRX Nasdaq
- PSQH Nasdaq
- Market Cap
- TCRX 90.5M
- PSQH 81.5M
- IPO Year
- TCRX 2021
- PSQH N/A
- Fundamental
- Price
- TCRX $1.38
- PSQH $1.94
- Analyst Decision
- TCRX Strong Buy
- PSQH Strong Buy
- Analyst Count
- TCRX 7
- PSQH 2
- Target Price
- TCRX $9.86
- PSQH $6.00
- AVG Volume (30 Days)
- TCRX 396.8K
- PSQH 588.8K
- Earning Date
- TCRX 05-06-2025
- PSQH 05-08-2025
- Dividend Yield
- TCRX N/A
- PSQH N/A
- EPS Growth
- TCRX N/A
- PSQH N/A
- EPS
- TCRX N/A
- PSQH N/A
- Revenue
- TCRX $4,421,000.00
- PSQH $23,199,434.00
- Revenue This Year
- TCRX $47.30
- PSQH $85.69
- Revenue Next Year
- TCRX $74.30
- PSQH $62.08
- P/E Ratio
- TCRX N/A
- PSQH N/A
- Revenue Growth
- TCRX N/A
- PSQH 308.01
- 52 Week Low
- TCRX $1.02
- PSQH $1.63
- 52 Week High
- TCRX $9.69
- PSQH $7.77
- Technical
- Relative Strength Index (RSI)
- TCRX 42.86
- PSQH 47.58
- Support Level
- TCRX $1.32
- PSQH $1.71
- Resistance Level
- TCRX $1.65
- PSQH $1.92
- Average True Range (ATR)
- TCRX 0.13
- PSQH 0.13
- MACD
- TCRX -0.01
- PSQH 0.03
- Stochastic Oscillator
- TCRX 14.63
- PSQH 54.76
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.